| The serotonin theory of depression: a systematic umbrella review of the evidence MAH Joanna Moncrieff, Ruth E Cooper, Tom Stockmann, Simone Amendola, Michael ... Molecular Psychiatry, 2022 | 563* | 2022 |
| Cannabinoids in attention-deficit/hyperactivity disorder: A randomised-controlled trial RE Cooper, E Williams, S Seegobin, C Tye, J Kuntsi, P Asherson European Neuropsychopharmacology 27 (8), 795-808, 2017 | 165 | 2017 |
| Validation of the mind excessively wandering scale and the relationship of mind wandering to impairment in adult ADHD FD Mowlem, C Skirrow, P Reid, S Maltezos, SK Nijjar, A Merwood, ... Journal of attention disorders 23 (6), 624-634, 2019 | 147 | 2019 |
| Omega-3 polyunsaturated fatty acid supplementation and cognition: A systematic review and meta-analysis RE Cooper, C Tye, J Kuntsi, E Vassos, P Asherson Journal of psychopharmacology 29 (7), 753-763, 2015 | 139 | 2015 |
| The effect of omega-3 polyunsaturated fatty acid supplementation on emotional dysregulation, oppositional behaviour and conduct problems in ADHD: A systematic review and meta … RE Cooper, C Tye, J Kuntsi, E Vassos, P Asherson Journal of affective disorders 190, 474-482, 2016 | 98 | 2016 |
| Effects of stimulants and atomoxetine on emotional lability in adults: a systematic review and meta-analysis TR Moukhtarian, RE Cooper, E Vassos, P Moran, P Asherson European Psychiatry 44, 198-207, 2017 | 63 | 2017 |
| Psychosocial interventions for people with schizophrenia or psychosis on minimal or no antipsychotic medication: A systematic review RE Cooper, N Laxhman, N Crellin, J Moncrieff, S Priebe Schizophrenia Research, 2019 | 57 | 2019 |
| Definitions of relapse in trials comparing antipsychotic maintenance with discontinuation or reduction for schizophrenia spectrum disorders: a systematic review J Moncrieff, NE Crellin, MA Long, RE Cooper, T Stockmann Schizophrenia research 225, 47-54, 2020 | 43 | 2020 |
| The effects of emotional lability, mind wandering and sleep quality on ADHD symptom severity in adults with ADHD B Helfer, RE Cooper, N Bozhilova, S Maltezos, J Kuntsi, P Asherson European Psychiatry 55, 45-51, 2019 | 43 | 2019 |
| Experiences of taking neuroleptic medication and impacts on symptoms, sense of self and agency: a systematic review and thematic synthesis of qualitative data. J Thompson, J., Stansfield, J., Cooper, R.E., Morant, N., Crellin, N., Moncrieff Social Psychiatry and Psychiatric Epidemiology., 2019 | 39* | 2019 |
| Randomised controlled trial of gradual antipsychotic reduction and discontinuation in people with schizophrenia and related disorders: the RADAR trial (Research into … SP Joanna Moncrieff, Glyn Lewis, Nick Freemantle, Sonia Johnson, Thomas R E ... BMJ Open, 2019 | 35 | 2019 |
| Mental health professionals’ views and experiences of antipsychotic reduction and discontinuation RE Cooper, E Hanratty, N Morant, J Moncrieff PLOS ONE 14 (6), 1-18, 2019 | 32 | 2019 |
| An analysis of views about supported reduction or discontinuation of antipsychotic treatment among people with schizophrenia and other psychotic disorders J Crellin, NE., Priebe, Morant, N., Lewis, G., Freemantle, N., Johnson, S ... BMC Psychiatry 22 (185), 2022 | 21 | 2022 |
| Electrophysiological correlates of spontaneous mind wandering in attention deficit/hyperactivity disorder. G Bozhilova, N., Cooper, R.E., Kuntsi, J., Asherson, P., Michelini Behavioural Brain Research, 2020 | 21 | 2020 |
| Opinion Piece: The case for establishing a minimal medication alternative for psychosis and schizophrenia R Cooper, J Mason, T Calton, J Richardson, J Moncrieff Psychosis, 2021 | 16 | 2021 |
| The effect of methylphenidate on very low frequency electroencephalography oscillations in adult ADHD RE Cooper, C Skirrow, C Tye, G McLoughlin, F Rijsdijk, T Banaschweski, ... Brain and cognition 86, 82-89, 2014 | 14 | 2014 |
| Antipsychotic dose reduction and discontinuation versus maintenance treatment in people with schizophrenia and other recurrent psychotic disorders in England (the RADAR trial … J Moncrieff, N Crellin, J Stansfeld, R Cooper, L Marston, N Freemantle, ... The Lancet Psychiatry 10 (11), 848-859, 2023 | 11 | 2023 |
| The costs incurred by the NHS in England due to the unnecessary prescribing of dependency-forming medications J Davies, RE Cooper, J Moncrieff, L Montagu, T Rae, M Parhi Addictive Behaviors 125, 107143, 2022 | 10 | 2022 |
| Experiences of reduction and discontinuation of antipsychotics: a qualitative investigation within the RADAR trial JM Nicola Morant, Maria Long, Sandra Jayacodi, Ruth Cooper, Johura Akther ... eClinicalMedicine, 2023 | 8 | 2023 |
| The case for including antipsychotics in the UK NICE guideline: “Medicines associated with dependence or withdrawal symptoms: safe prescribing and withdrawal management for adults” RE Cooper, LM Grunwald, M Horowitz Psychosis, 2020 | 8 | 2020 |
